159 related articles for article (PubMed ID: 26213925)
21. Altered expression of two-pore domain potassium (K2P) channels in cancer.
Williams S; Bateman A; O'Kelly I
PLoS One; 2013; 8(10):e74589. PubMed ID: 24116006
[TBL] [Abstract][Full Text] [Related]
22. Molecular identification of the dominant-negative, splicing isoform of the two-pore domain K(+) channel K(2P)5.1 in lymphoid cells and enhancement of its expression by splicing inhibition.
Endo K; Kurokawa N; Kito H; Nakakura S; Fujii M; Ohya S
Biochem Pharmacol; 2015 Dec; 98(3):440-52. PubMed ID: 26475531
[TBL] [Abstract][Full Text] [Related]
23. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases.
Beeton C; Wulff H; Standifer NE; Azam P; Mullen KM; Pennington MW; Kolski-Andreaco A; Wei E; Grino A; Counts DR; Wang PH; LeeHealey CJ; S Andrews B; Sankaranarayanan A; Homerick D; Roeck WW; Tehranzadeh J; Stanhope KL; Zimin P; Havel PJ; Griffey S; Knaus HG; Nepom GT; Gutman GA; Calabresi PA; Chandy KG
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17414-9. PubMed ID: 17088564
[TBL] [Abstract][Full Text] [Related]
24. The role of T cell potassium channels, KV1.3 and KCa3.1, in the inflammatory cascade in ulcerative colitis.
Hansen LK
Dan Med J; 2014 Nov; 61(11):B4946. PubMed ID: 25370966
[TBL] [Abstract][Full Text] [Related]
25. Segment-specific expression of 2P domain potassium channel genes in human nephron.
Levy DI; Velazquez H; Goldstein SA; Bockenhauer D
Kidney Int; 2004 Mar; 65(3):918-26. PubMed ID: 14871411
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation.
Kang JA; Park SH; Jeong SP; Han MH; Lee CR; Lee KM; Kim N; Song MR; Choi M; Ye M; Jung G; Lee WW; Eom SH; Park CS; Park SG
Proc Natl Acad Sci U S A; 2016 Aug; 113(31):8771-6. PubMed ID: 27439875
[TBL] [Abstract][Full Text] [Related]
27. Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases.
Beeton C; Pennington MW; Wulff H; Singh S; Nugent D; Crossley G; Khaytin I; Calabresi PA; Chen CY; Gutman GA; Chandy KG
Mol Pharmacol; 2005 Apr; 67(4):1369-81. PubMed ID: 15665253
[TBL] [Abstract][Full Text] [Related]
28. Re-expression of a developmentally restricted potassium channel in autoimmune demyelination: Kv1.4 is implicated in oligodendroglial proliferation.
Herrero-Herranz E; Pardo LA; Bunt G; Gold R; Stühmer W; Linker RA
Am J Pathol; 2007 Aug; 171(2):589-98. PubMed ID: 17600124
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of two-pore domain potassium channels in rat cerebellar granule neurons.
Burgos P; Zúñiga R; Domínguez P; Delgado-López F; Plant LD; Zúñiga L
Biochem Biophys Res Commun; 2014 Oct; 453(4):754-60. PubMed ID: 25305496
[TBL] [Abstract][Full Text] [Related]
30. The potassium channels TASK2 and TREK1 regulate functional differentiation of murine skeletal muscle cells.
Afzali AM; Ruck T; Herrmann AM; Iking J; Sommer C; Kleinschnitz C; Preuβe C; Stenzel W; Budde T; Wiendl H; Bittner S; Meuth SG
Am J Physiol Cell Physiol; 2016 Oct; 311(4):C583-C595. PubMed ID: 27488672
[TBL] [Abstract][Full Text] [Related]
31. Toxins Targeting the Kv1.3 Channel: Potential Immunomodulators for Autoimmune Diseases.
Zhao Y; Huang J; Yuan X; Peng B; Liu W; Han S; He X
Toxins (Basel); 2015 May; 7(5):1749-64. PubMed ID: 25996605
[TBL] [Abstract][Full Text] [Related]
32. Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block.
Matheu MP; Beeton C; Garcia A; Chi V; Rangaraju S; Safrina O; Monaghan K; Uemura MI; Li D; Pal S; de la Maza LM; Monuki E; Flügel A; Pennington MW; Parker I; Chandy KG; Cahalan MD
Immunity; 2008 Oct; 29(4):602-14. PubMed ID: 18835197
[TBL] [Abstract][Full Text] [Related]
33. CCR2-dependent dendritic cell accumulation in the central nervous system during early effector experimental autoimmune encephalomyelitis is essential for effector T cell restimulation in situ and disease progression.
Clarkson BD; Walker A; Harris MG; Rayasam A; Sandor M; Fabry Z
J Immunol; 2015 Jan; 194(2):531-41. PubMed ID: 25505278
[TBL] [Abstract][Full Text] [Related]
34. K+ channel alterations in the progression of experimental autoimmune encephalomyelitis.
Jukkola PI; Lovett-Racke AE; Zamvil SS; Gu C
Neurobiol Dis; 2012 Aug; 47(2):280-93. PubMed ID: 22560931
[TBL] [Abstract][Full Text] [Related]
35. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C
J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770
[TBL] [Abstract][Full Text] [Related]
36. The two-pore domain K2 P channel TASK2 drives human NK-cell proliferation and cytolytic function.
Schulte-Mecklenbeck A; Bittner S; Ehling P; Döring F; Wischmeyer E; Breuer J; Herrmann AM; Wiendl H; Meuth SG; Gross CC
Eur J Immunol; 2015 Sep; 45(9):2602-14. PubMed ID: 26140335
[TBL] [Abstract][Full Text] [Related]
37. Kv1.3/Kv1.5 heteromeric channels compromise pharmacological responses in macrophages.
Villalonga N; Escalada A; Vicente R; Sánchez-Tilló E; Celada A; Solsona C; Felipe A
Biochem Biophys Res Commun; 2007 Jan; 352(4):913-8. PubMed ID: 17157812
[TBL] [Abstract][Full Text] [Related]
38. A Kv1.3 channel-specific blocker alleviates neurological impairment through inhibiting T-cell activation in experimental autoimmune encephalomyelitis.
Yuan XL; Zhao YP; Huang J; Liu JC; Mao WQ; Yin J; Peng BW; Liu WH; Han S; He XH
CNS Neurosci Ther; 2018 Oct; 24(10):967-977. PubMed ID: 29577640
[TBL] [Abstract][Full Text] [Related]
39. The cooling compound icilin attenuates autoimmune neuroinflammation through modulation of the T-cell response.
Ewanchuk BW; Allan ERO; Warren AL; Ramachandran R; Yates RM
FASEB J; 2018 Mar; 32(3):1236-1249. PubMed ID: 29114087
[TBL] [Abstract][Full Text] [Related]
40. TWIK-related acid-sensitive K+ channel 1 (TASK1) and TASK3 critically influence T lymphocyte effector functions.
Meuth SG; Bittner S; Meuth P; Simon OJ; Budde T; Wiendl H
J Biol Chem; 2008 May; 283(21):14559-70. PubMed ID: 18375952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
